Popular cannabis sleep gummies may have a hidden dark side — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- CBN caused mice to develop tolerance after repeated exposure, with reduced responsiveness observed over three days of twice-daily dosing, according to a University of Connecticut study.
- Mice exhibited physical withdrawal symptoms such as head twitching and paw fluttering after CBN was discontinued, indicating potential for physical dependence.
- CBN produced psychoactive effects similar to THC in mice trained to recognize THC, suggesting overlapping subjective experiences despite CBN’s reputation as a milder cannabinoid.
- Steven Kinsey warns consumers to be aware of risks, noting CBN is widely marketed as a safe herbal supplement even though long-term human effects are unknown.
- Olivia Vanegas highlights the gap between aggressive marketing of minor cannabinoids and the lack of scientific understanding about their risks with repeated use.
- CBN showed anti-inflammatory benefits at low doses without psychoactivity, but also impaired immune response during a simulated bacterial challenge, raising additional safety concerns.
Why it matters: Consumers using CBN sleep gummies may face unknown dependence risks, as the compound shows tolerance, withdrawal, and THC-like effects in mice—yet it remains widely available with minimal regulation or long-term safety data, creating a gap between market availability and scientific understanding.
Ask SkimNews
